| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Apr 11, 2025 | Sell(S) | 51K | $11.49 | $584K | 3.9M |
| Apr 10, 2025 | Sell(S) | 50K | $10.87 | $544K | 4.0M |
| Apr 9, 2025 | Sell(S) | 2K | $11.76 | $19K | 4.0M |
| Apr 9, 2025 | Sell(S) | 3K | $10.75 | $37K | 4.0M |
| Apr 9, 2025 | Sell(S) | 35K | $9.93 | $351K | 4.0M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-25-017592) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for ARROWHEAD PHARMACEUTICALS, INC.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.